AnnouncementDetails

Actions

Dallah Healthcare Company invites Its Shareholders to The General Assembly Meeting. (The First Meeting)

Element ListExplanation
Introduction The Board of Directors of Dallah Healthcare company are pleased to invite the shareholders to the General Assembly Meeting, which will be held in Riyadh at Dallah hospital –north clinics(3ed floor – tinning room ) on 09 October, 2019 at 06:30 p.m.
City and Location of the General Assembly's Meeting Riyadh at Dallah hospital –North clinics (3ed floor – tinning room)
URL for the Meeting Location https://goo.gl/ccpcZR
Date of the General Assembly's Meeting 2019-10-09 Corresponding to 1441-02-10
Time of the General Assembly's Meeting 18:30
Attendance Eligibility Each shareholder who is registered in the Company's shareholders Book with Edaa at the end of the trading session prior to the Assembly meeting shall be entitled to attend the Assembly and according to the rules and regulations. The right to register for the attendance of the Assembly shall end at the time of the starting the Assembly. In addition, the right to vote on the meeting agenda shall end at the start of the counting of votes
Quorum for Convening the General Assembly's Meeting The General Assembly meeting shall be held in the presence of shareholders representing quarter of the company's capital
General Assembly Meeting Agenda 1- To elect members for the Board of Directors of Dallah Healthcare Company for the new period of three years starting on 21th October 2019 and until 20th October 2022 (Attached Candidates CVs)

2- To vote on the formation of the Audit Committee for new period (three years term) that starts on 21th October 2019 and until 20th October 2022, and on its duties and internal regulations as well as on the remuneration of its members. Note that the candidates are as follows (Attached Candidates CVs):

- Fahd bin Abdullah al-Qasim

- Abdullah bin Turki Al-Sudairy

- Abdulrahman Bin Saleh Al – Khulaifi

- Khalid bin Mohammed Al-Khwaiter

3- Vote on the company's corporate social responsibility policy

Proxy Form
E-Vote The shareholders who are registered in the Tadawulaty electronic trading services can remotely vote on the items of the General Assembly Meeting, through (electronic voting) service at (https://www.tadawulaty.com.sa) free of charge (voting and registration) noting that the remote voting will start at 10:00 AM on October 6, 2019 and continue until 04:00 PM on the day of the Meeting
Eligibility for Attendance Registration and Voting Eligibility for Registering the Attendance of the General Assembly’s Meeting Ends upon the Convenience of the General Assembly’s Meeting. Eligibility for Voting on the Business of the Meeting Agenda Ends upon the Counting Committee Concludes Counting the Votes
Method of Communication For any inquire please contact Investor Relations at

Telephone: +966 11 2255065 (5769, 5004)

Fax: +966 11 4550803

Email: IR@Dallahhealth.com

Additional Information Each shareholder has the right to attend the General Assembly Meeting, whether in person or by proxy, subject to presentation of corroborating evidence (Commercial Registration if the shareholder is a company) or a written power of an attorney endorsed by the Chamber of Commerce, a licensed bank or an Authorized Person in the Kingdom, provided that the authorizing shareholder holds an account with the attesting bank or Authorized Person, Notary public or Persons licensed for attesting. The Authorization could be to another shareholder, other than a member of the Board of Directors or employee of the Company, to attend on their behalf. The shareholder or its proxy must provide a copy of the proxy letter to the Company at least two days prior to the assembly meeting By hand to Alnakheel tower 2end floor - king Fahad road, Riyadh or by email through the Investor Relation Email (IR@Dallahhealth.com), and the proxy shall present the original proxy letter prior to the assembly meeting.
Attached Documents

The Capital Market Authority and the Saudi Stock Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.

Company Profile

Actions

Company Profile

Summary

Last Price Net Change
44.3 -1.6 (-3.49%)
Value Traded (SAR) Volume Traded
6,939,483.75 155,050